» Articles » PMID: 31183587

WHO Grade I Meningiomas: Classification-tree for Prognostic Factors of Survival

Overview
Journal Neurosurg Rev
Specialty Neurosurgery
Date 2019 Jun 12
PMID 31183587
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

World Health Organization (WHO) grade I meningiomas are intracranial extracerebral tumors, in which microsurgery as a stand-alone therapy provides high rates of disease control and low recurrence rates. Our aim was to identify prognostic factors of overall survival and time-to-retreat (OS; TTR) in a cohort of patients with surgically managed WHO grade I meningioma. Patients with WHO grade I meningiomas from a retrospectively (1990 to 2002) and prospectively managed (2003 to 2010) databank of Oslo University Hospital, Norway, were included. The mean follow-up was 9.2 ± 5.7 years, with a total of 11,414 patient-years. One thousand three hundred fifty-five patients were included. The mean age was 58 ± 13.2, mean Karnofsky Performance Status (KPS) 92.6 ± 26.1 and female-to-male ratio 2.5:1. The 1-year, 5-year, 10-year, 15-year, and 20-year probabilities were 0.98, 0.91, 0.87, 0.84, and 0.8 for TTR. Patient age (OR 0.92 [0.91, 0.94]), male sex (OR 0.59 [0.45, 0.76]), preoperative KPS ≥ 70 (OR 2.22 [1.59, 3.13]), skull base location (OR 0.77 [0.60, 1]), and the occurrence of a postoperative hematoma (OR 0.44 [0.26, 0.76]) were identified as independent prognostic factors of OS. Patient age (OR 1.02 [1.01, 1.03]) and skull base location (OR 0.30 [0.21, 0.45]) were independent predictors of decreased PFS. Using a recursive partitioning analysis, we suggest a classification tree for the prediction of 5-year PFS based on patient and tumor characteristics. The findings from this cohort of meningioma WHO I patients helps to identify patients at risk of recurrence and tailor the therapeutic management.

Citing Articles

The efficacy of preoperative MRI features in the diagnosis of meningioma WHO grade and brain invasion.

Jiang J, Yu J, Liu X, Deng K, Zhuang K, Lin F Front Oncol. 2023; 12:1100350.

PMID: 36741697 PMC: 9890055. DOI: 10.3389/fonc.2022.1100350.


Management of Recurrent Meningiomas: State of the Art and Perspectives.

Corniola M, Meling T Cancers (Basel). 2022; 14(16).

PMID: 36010988 PMC: 9406695. DOI: 10.3390/cancers14163995.


Why we need new classification models in meningioma management.

Corniola M Acta Neurochir (Wien). 2022; 164(5):1381-1383.

PMID: 35067786 DOI: 10.1007/s00701-022-05127-8.


Neuropsychological Outcomes after Surgery for Olfactory Groove Meningiomas.

Constanthin P, Gondar R, Fellrath J, Wyttenbach I, Tizi K, Weman L Cancers (Basel). 2021; 13(11).

PMID: 34063924 PMC: 8196649. DOI: 10.3390/cancers13112520.


Comparative Analysis of the MRI Characteristics of Meningiomas According to the 2016 WHO Pathological Classification.

Yu J, Chen F, Zhang H, Zhang H, Luo S, Huang G Technol Cancer Res Treat. 2020; 19:1533033820983287.

PMID: 33356976 PMC: 7768868. DOI: 10.1177/1533033820983287.

References
1.
Escribano Mesa J, Alonso Morillejo E, Parron Carreno T, Huete Allut A, Narro Donate J, Mendez Roman P . Risk of Recurrence in Operated Parasagittal Meningiomas: A Logistic Binary Regression Model. World Neurosurg. 2017; 110:e112-e118. DOI: 10.1016/j.wneu.2017.10.087. View

2.
Simpson D . The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry. 1957; 20(1):22-39. PMC: 497230. DOI: 10.1136/jnnp.20.1.22. View

3.
Meling T, Da Broi M, Scheie D, Helseth E, Smoll N . Meningioma Surgery-Are We Making Progress?. World Neurosurg. 2019; 125:e205-e213. DOI: 10.1016/j.wneu.2019.01.042. View

4.
Sanna M, Bacciu A, Falcioni M, Taibah A, Piazza P . Surgical management of jugular foramen meningiomas: a series of 13 cases and review of the literature. Laryngoscope. 2007; 117(10):1710-9. DOI: 10.1097/MLG.0b013e3180cc20a3. View

5.
Meling T, Da Broi M, Scheie D, Helseth E . Skull base versus non-skull base meningioma surgery in the elderly. Neurosurg Rev. 2018; 42(4):961-972. DOI: 10.1007/s10143-018-1005-6. View